{
  "thesis_id": "P3",
  "role": "scenario_branch",
  "findings": "The P3 forecast posits that autonomous science will shift the bottleneck from model-driven discovery to experimental throughput. Scenario analysis reveals three trajectories. Base: robotic wet-lab capacity expands gradually, making experiment generation the rate-limiter by 2029, consistent with the thesis. Upside: modular and cloud-based autonomous labs scale rapidly, compressing iteration cycles and creating a new bottleneck in hypothesis-generation or data interpretation. Downside: AI model improvements plateau, or wet-lab automation proves too expensive/inflexible, leaving model quality as the enduring bottleneck. The branch identifies early observables (e.g., first pharma partnership explicitly citing lab throughput as the bottleneck, or a new DOE testbed announcement) to discriminate between scenarios.",
  "proposed_nodes": [
    {
      "id": "n-scenario-base-p3-autonomous-experiment-bottleneck-by-2029-5a2f1e",
      "kind": "scenario",
      "label": "Base: experiment throughput becomes the dominant bottleneck by 2029",
      "description": "Autonomous labs (e.g., national lab testbeds, pharma-internal platforms) increase throughput 10x but demand for experiments grows faster. AI model discovery output accelerates, flooding limited wet-lab capacity. Multiple pharma/materials companies publicly cite lab capacity as the critical constraint. Model inference cost falls further, but physical testing remains the gating factor for new materials/therapies.",
      "confidence": 0.55,
      "thesis_id": "P3",
      "scenario_type": "base"
    },
    {
      "id": "n-scenario-upside-p3-autonomous-lab-breakthrough-32bb7f",
      "kind": "scenario",
      "label": "Upside: exponential growth in autonomous lab capacity beyond current trends",
      "description": "Breakthroughs in modular, self-assembling, or AI-controlled labs (e.g., cloud-based chemistry platforms, fully automated synthesis and testing pipelines) commoditize experimentation. Throughput per dollar improves 100x. The bottleneck shifts earlier: from experimentation to hypothesis generation and model interpretability, or to downstream regulatory/validation steps. The 2029 kill condition is triggered because model-only companies succeed without expanding their own wet-lab throughput.",
      "confidence": 0.15,
      "thesis_id": "P3",
      "scenario_type": "upside"
    },
    {
      "id": "n-scenario-downside-p3-model-discovery-remains-bottleneck-f1a4cc",
      "kind": "scenario",
      "label": "Downside: model discovery remains the bottleneck, or AI fails to scale",
      "description": "AI-generated hypotheses hit diminishing returns, or autonomous lab hardware stalls due to cost, complexity, or lack of standardization. Experiment throughput may be ample relative to the quality of AI-generated candidates. The bottleneck reverts to model accuracy, data quality, or the creativity of AI discovery. Kill condition (model-only successes without material wet-lab expansion) would then hold—i.e., the thesis would be falsified.",
      "confidence": 0.30,
      "thesis_id": "P3",
      "scenario_type": "downside"
    },
    {
      "id": "n-observable-p3-first-public-bottleneck-citation-by-pharma-9e448d",
      "kind": "observable",
      "label": "First major pharma/chemical company publicly states AI discovery bottleneck is lab throughput",
      "description": "A press release, earnings call, or publication from a top-20 pharma or materials firm explicitly saying that AI models generate too many candidates for their existing wet-lab capacity.",
      "confidence": 0.7,
      "thesis_id": "P3",
      "scenario_support": "strongly supports base scenario"
    },
    {
      "id": "n-observable-p3-doe-testbed-award-targets-automation-scale-3a7e81",
      "kind": "observable",
      "label": "DOE or national lab testbed award explicitly aimed at scaling autonomous experimentation capacity",
      "description": "A new funding program from DOE, NSF, or a large national lab that cites AI hypothesis overload as the rationale and funds robotic platforms to close the loop.",
      "confidence": 0.65,
      "thesis_id": "P3",
      "scenario_support": "supports base or upside scenario"
    },
    {
      "id": "n-observable-p3-model-only-success-without-lab-expansion-9b21a6",
      "kind": "observable",
      "label": "Model-only AI company achieves commercially validated therapy/material without materially growing wet-lab throughput",
      "description": "E.g., an AI-first biotech files an IND or launches a product where the AI model replaced most experimental cycles, and the company’s internal lab capacity remained small. This would kill the thesis per the kill condition.",
      "confidence": 0.5,
      "thesis_id": "P3",
      "scenario_support": "directly falsifies base scenario, supports downside"
    }
  ],
  "proposed_edges": [
    {
      "src": "n-forecast-clause-autonomous-science-shifts-the-bottleneck-from-model-discovery-to-60c389a9",
      "dst": "n-scenario-base-p3-autonomous-experiment-bottleneck-by-2029-5a2f1e",
      "rel": "resolved_by_scenario",
      "confidence": 0.55,
      "rationale": "The forecast clause resolves via the base scenario trajectory if experiment throughput indeed becomes the binding constraint by 2029."
    },
    {
      "src": "n-forecast-clause-autonomous-science-shifts-the-bottleneck-from-model-discovery-to-60c389a9",
      "dst": "n-scenario-upside-p3-autonomous-lab-breakthrough-32bb7f",
      "rel": "falsified_by_scenario",
      "confidence": 0.15,
      "rationale": "If autonomous lab capacity explodes, the bottleneck moves elsewhere, contradicting the specific bottleneck claim."
    },
    {
      "src": "n-forecast-clause-autonomous-science-shifts-the-bottleneck-from-model-discovery-to-60c389a9",
      "dst": "n-scenario-downside-p3-model-discovery-remains-bottleneck-f1a4cc",
      "rel": "falsified_by_scenario",
      "confidence": 0.30,
      "rationale": "If model discovery remains the bottleneck, the thesis fails."
    },
    {
      "src": "n-thesis-p3-autonomous-science-shifts-the-bottleneck-from-model-discovery-to-exper-2d0ad3e9",
      "dst": "n-scenario-base-p3-autonomous-experiment-bottleneck-by-2029-5a2f1e",
      "rel": "implies_scenario",
      "confidence": 0.65,
      "rationale": "The thesis argues that the bottleneck will shift to experimental throughput; the base scenario is the direct realization of this thesis."
    },
    {
      "src": "n-scenario-base-p3-autonomous-experiment-bottleneck-by-2029-5a2f1e",
      "dst": "n-observable-p3-first-public-bottleneck-citation-by-pharma-9e448d",
      "rel": "produces_observable",
      "confidence": 0.8,
      "rationale": "If the base scenario is unfolding, a public bottleneck admission by pharma is a near-certain early signal."
    },
    {
      "src": "n-scenario-upside-p3-autonomous-lab-breakthrough-32bb7f",
      "dst": "n-observable-p3-doe-testbed-award-targets-automation-scale-3a7e81",
      "rel": "produces_observable",
      "confidence": 0.75,
      "rationale": "Upside would likely be preceded or accompanied by major public investment in scaling autonomous experimentation."
    },
    {
      "src": "n-scenario-downside-p3-model-discovery-remains-bottleneck-f1a4cc",
      "dst": "n-observable-p3-model-only-success-without-lab-expansion-9b21a6",
      "rel": "produces
